Pharmaceutical Manufacturing Standards: A Technical Comparison of the EU GMP and WHO GMP Guidelines

In pharmaceutical manufacturing, quality assurance processes are carried out within the framework of Good Manufacturing Practice (GMP) set by international authorities. The two most widely referenced guidelines in this field are those published by the World Health Organization (WHO) and the European Medicines Agency (EMA). Although the core purpose of both guidelines is to protect patient safety and product quality, there are clear differences in technical detail and mandatory requirements.

WHO GMP: Global Procurement and Basic Standards

WHO GMP was developed primarily to guide medicines regulators in developing countries and to set minimum standards for global health programs.

• Use: It is the primary criterion for companies participating in international medicine tenders of UNICEF, GAVI and the World Health Organization.
• Scope: It focuses mainly on basic manufacturing principles and general processes.
• Flexibility: Compared with EU standards, it leaves the manufacturer more latitude on technical requirements.

EU GMP: Technical Details and Regulatory Requirements

The EU GMP guideline published by the European Union is regarded as one of the most comprehensive and technically detailed regulations in the world.

• Mandatory: Compliance with this guideline is mandatory for all medicines placed on the European Union market (wherever they are manufactured).
• Technical Focus: It sets much more specific parameters for biotechnological products requiring advanced technology and for sterile production lines.
• Currency: Its annexes, such as "Annex 1" on sterile manufacturing in particular, are revised regularly in line with technological developments.

Operational and Technical Differences

The table below summarizes the technical differences between these two guidelines for critical processes on the production site:

Topic

EU GMP Requirements

WHO GMP Requirements

Sterile Manufacturing

Under Annex 1, HVAC performance tests, particle limits and airflow (smoke) test criteria are defined with exact figures.

Built on basic cleanroom principles; however, test limits and application methods are not detailed.

Risk Management

The Quality Risk Management (QRM) process is mandatory for every manufacturing stage, with written, evidence-based reporting.

The concept of risk management is emphasized; however, no specific report format or methodology is imposed.

Internal Audit

Conducting self-inspection processes annually is a regulatory requirement.

Conducting internal audits is a recommended practice; however, no periodic requirement is specified.

Documentation

In addition to batch records and traceability, electronic data integrity criteria are defined in detail.

Record keeping is mandatory; however, definitions regarding data format and level of detail are open-ended.

Validation & Qualification

Under Annex 15, the IQ (Installation), OQ (Operational) and PQ (Performance) steps must be presented together with acceptance criteria.

The need for validation is stated; however, the test scope and acceptable limit values are left to the manufacturer.

Strategic Assessment

Which GMP standard manufacturers place at the center of their operations depends on the regulatory expectations of the markets they target.

WHO GMP is a suitable starting point for companies that want to take part in global tender processes and standardize their basic pharmaceutical manufacturing processes.

EU GMP, on the other hand, provides the technical discipline needed to work with high-sensitivity product groups (sterile, biological, etc.) and to access highly regulated markets such as the European Union.